The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the third point i would make of broad general applicability i would have guessed any drug that works is going to work in both sexes and that's mostly wrong we have two drugs rapamycin and one we didn't mention the amino acid glycine which have equally strong effects in males and females
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
those are important research questions and we could easily take three or four or five times as many really good new labs in aging and devote them to trying to tease out those puzzles